Strategy Dinner Home Clinical Ink San Francisco 2019 - Proventa International | Management Consultancy
  • +44 (0)20 70961222



Industry thought leaders will gather for an interactive roundtable discussion dinner to exchange their vision of paradigm shifts in early clinical development that are already underway and yet to happen. The focus will be on practical aspects of implementation of innovative approaches to achieve Proof-of-Concept results in record time. We will share best practices and real-life case studies, exploring them from different perspectives – regulatory, sponsor, clinical site and patient.

Attendees will be able to address these issues and leave the day better informed on how to:

Develop an efficient strategy to reach Proof-of-Concept quicker

Overcome challenges in execution of complex exploratory protocols

Balance scientific/business interests & regulatory requirements



May 21 2019

5:00PM - 10:00PM


Marriott Union Square, San Francisco



Insights Into How ePRO and eCOA Impact Clinical Trials


Insights Into How ePRO and eCOA Impact Clinical Trials

In association with:

Clinical Ink is a global clinical trial technology company that is transforming the clinical trial experience. Founded in 2007, the Company’s proven and future-built Capture platform, which includes solutions for EDC replacement, eCOA, ePRO and more, accelerates time to value while delivering scientific results that matter. With offices in Winston-Salem, NC, and Philadelphia, PA, Clinical Ink is advancing the business model responsible for bringing new treatments to market.






Request Agenda

I Agree
***The information you provided in this website is confidential and the company will strictly forbidden to share any part of these information with any third party without a written consent of the sender. Please read our Terms of Service and Privacy Policy


Subscribe to our newsletter to receive latest updates of events & articles